ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,749.00
0.35%
S&P ASX All Technology
3,067.50
0.14%
Brent Oil
82.585
0.00%
US Dollar vs AUD
1.50761
0.00%
Bitcoin
60,989.05
0.31%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Syneron Medical Ltd. - Ordinary Shares (ELOS)

  7. Syneron Medical Ltd. - Ordinary Shares (ELOS) News

ELOS

Syneron Medical Ltd. - Ordinary Shares (ELOS)

Syneron Medical Ltd. - Ordinary Shares
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ELOS
DateTimeSourceHeadlineSymbolCompany
01/08/201723:49Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
27/07/201723:01Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
18/07/201700:57Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
18/07/201700:54Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
18/07/201700:53Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
18/07/201700:51Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
18/07/201700:51Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
17/07/201722:51Edgar (US Regulatory)(25-NSE)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
17/07/201721:46Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
17/07/201721:30PR Newswire (US)Syneron Candela Completes Previously Announced Transaction with Funds Advised by Apax Partners and Becomes a Private CompanyNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
08/07/201701:55Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
16/06/201704:33Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
15/06/201723:22PR Newswire (US)Syneron Candela Announces Shareholder Approval of Proposed Acquisition by Funds Advised by Apax PartnersNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
31/05/201706:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
23/05/201722:37Edgar (US Regulatory)Specialized Disclosure Report (sd)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
19/05/201700:35Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
18/05/201707:00PR Newswire (US)Syneron Medical Reports First Quarter 2017 Revenue of $66.9 MillionNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
16/05/201706:44Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
11/05/201721:45Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
10/05/201720:49Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
10/05/201720:13Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
10/05/201720:00PR Newswire (US)Syneron Candela Announces End of Go-Shop PeriodNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
02/05/201706:37Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
20/04/201700:50Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
11/04/201700:11Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
04/04/201706:42Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
04/04/201702:31Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
28/03/201705:43Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
27/03/201719:00PR Newswire (US)Syneron Candela Announces CE Mark for CO2RE® IntimaNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
24/03/201707:34Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
 Showing the most relevant articles for your search:NASDAQ:ELOS

Your Recent History

NASDAQ
AMZN
Amazon.com
ASX
XAO
Australian SE All Ordina...
ASX
CSL
CSL
SPI
SP500
S&P 500
ASX
WDC
Westfield
ASX
ORG
Origin Energy
ASX
MQG
Macquarie
ASX
XMM
S&P ASX 300 Metals and M...
FTSE
UKX
FTSE 100
ASX
TLS
Telstra
FX
AUDUSD
AUD vs US Dollar
NYSE
DIS
Walt Disney
ASX
ANZ
Australia And New Zealan...
NYSE
JPM
JP Morgan Chase
ASX
WPL
Woodside Petroleum
ASX
AMP
AMP
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved